Delivery Order SPE2DX15D9348-SPE2DX24FBEBJ

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $14K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,007.82, is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,717.52 firm-fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant product. The contract has an ultimate completion date of April 5, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle (IDV) contract, SPE2DB, with DLA valued up to $4,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device, and has a ceiling value of $2,082.93. The contract is a firm fixed-price delivery order with a period of performance through March 13, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, at a firm fixed price of $14,293.80. The contract has a completion date of March 26, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Vehicle (IDV) contract with the DLA, valued up...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, with a ceiling value of $7,550.16 and a period of performance through March 28, 2022. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,082.93, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military healthcare facilities. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2025. DMS Pharmaceutical Group Inc. holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,943.10, is for the procurement of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $3,471.55 and a period of performance through December 27, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive, with a ceiling value of $26,383.78. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. This contract is not associated with any set-aside designation. DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at up to $7,146.90, is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant product. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding an Indefinite Delivery Contract (IDC) valued up to...
  • SPE2DX15D9348
    Indefinite Delivery Contract
  • SPE2DX15D9348-SPE2DX24FBEBJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, at a ceiling value of $14,293.80. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products, including common medications and specialized drugs, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 11/15/24, 9:15 AM